In 2012 I founded the Inkkas company (www.inkkas.com) and successfully scaled the company from zero into a multi-million dollar brand and then sold the company in 2016 to celebrity investor Marcus Lemonis. The process of launching and scaling a new Ecommerce brand from scratch was riddled with many challenges along the way. Some of the major challenges included branding, go-to-market strategy, fulfillment, sourcing, web design & development, customer acquisition, paid advertising, conversion rate optimization and more. Along with my founding team, we were able to overcome every obstacle and devise a customer acquisition strategy the led to success.

Shark Clean AU is the sister brand to Ninja Kitchen and they both faced similar challenges.

The brand was struggling to improve the ROAS of their online store above 300%, after getting a taste of 800 - 900% during the pandemic, when people being stuck at home all day every day was beneficial to a brand like theirs. The brand was already familiar to consumers who were used to seeing it at stores like Harvey Norman and Kmart, but now could no longer shop at those stores. Another challenge was not being able to offer discounts on their products deeper than the stockist retailer were offering.

The target ROAS was 500 - 600%. The channels they were using were Facebook/Instagram Ads and Google Ads. Facebook was an area of concern as they did not see consistent returns there, although the channel did very well during lockdowns.

Their profit margins were normally high before to working with DIDO AGENCY, but they weren't fully exploiting their network of former buyers. Yokkao realized that it needed to increase its marketing activities in order to stay in touch with clients between transactions.

NCI did not have an SEO strategy or staff, but it also had 150 subdomains run by different departments and on different CMS systems. Additionally, Google had recently rolled out its symptom panels. As a result, even its expert written content was not ranking for its ideal terms, and its cancer clinical trials section of its site was not ranking for the vast majority of cancer clinical trial keywords.